Selective TAK1 Inhibitor Development Targeting autoimmune and inflammatory diseases through the use of highly selective protein kinase inhibitors Unmet Medical...Read More
Total raised: $2.6M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 30.08.2024 | Grant | $2.6M | - |
Mentions in press and media 5
| Date | Title | Description |
| 30.08.2024 | The Sound of Silence: Protecting Your Hearing in a Noisy World | Hearing is a fragile thread that connects us to the world. It’s the melody of laughter, the rustle of leaves, and the whisper of loved ones. Yet, this vital sense often goes unnoticed until it fades. Hearing loss is a silent thief, creeping... |
| 30.08.2024 | A New Dawn in Autoimmune and Cancer Detection: NIH Grants Propel Innovation | In the realm of medical innovation, funding is the lifeblood that fuels discovery. Recently, two biopharmaceutical companies received significant grants from the National Institutes of Health (NIH), marking a pivotal moment in the fight aga... |
| 30.08.2024 | EVOQ Therapeutics Receives $2M Grant | EVOQ Therapeutics, an Ann Arbor, CA-based biopharmaceutical company providing disease-specific immune modulators, received a $2M grant from National Institutes of Health (NIH). The company intends to use the amount to advance novel therapie... |
| 30.08.2024 | EydisBio Receives $2.6M Grant | EydisBio, a Durham, NC-based pharmaceutical company, received a $2.6M SBIR Grant from National Institute of Health’s (NIH) National Heart, Lung, and Blood Institute (NHLBI). The company intends to use the amount to further support its ongoi... |
| 29.02.2024 | NCBiotech awards $1.5 million in grants, loans in latest quarter | The North Carolina Biotechnology Center awarded 19 grants and loans totaling more than $1.5 million to universities, bioscience companies and non-profit organizations in the second quarter of its fiscal year. The awards, made in October, No... |